发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 325 |
| CHINA MAINLAND | 199 |
| France | 160 |
| GERMANY (FED REP GER) | 133 |
| Sweden | 83 |
| Italy | 63 |
| Netherlands | 58 |
| Canada | 51 |
| England | 46 |
| Switzerland | 38 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| INSTITUT NATIONAL DE LA SANTE ET DE LA ... | 134 |
| UNICANCER | 92 |
| UNIVERSITE DE PARIS | 90 |
| ASSISTANCE PUBLIQUE HOPITAUX PARIS (APH... | 83 |
| SORBONNE UNIVERSITE | 78 |
| KAROLINSKA INSTITUTET | 68 |
| HELMHOLTZ ASSOCIATION | 51 |
| UNIVERSITE PARIS SACLAY | 48 |
| CENTRE NATIONAL DE LA RECHERCHE SCIENTI... | 40 |
| CORNELL UNIVERSITY | 34 |
文章引用情况
1
Immunological effects of BRAF plus MEK inhibition2
Recruitment of CCR2(+) tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer3
Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors4
Predicting T cell recognition of MHC class I restricted neoepitopes5
Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment6
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression!7
Treatment-naive HPV plus head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy8
Antibiotic use and the efficacy of immune checkpoint inhibitors in cancer patients: a pooled analysis of 2740 cancer patients9
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models10
A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo